MicroRNA-206 inhibits metastasis of triple-negative breast cancer by targeting transmembrane 4 L6 family member 1

References

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.24399786
   PubMed Web of Science ®Google Scholar
• Harder H, Langridge C, Solis-Trapala I, et al. Post-operative exercises after breast cancer surgery: results of a RCT evaluating standard care versus standard care plus additional yoga exercise. Eur J Integr Med. 2015;7(3):202–210. doi:10.1016/j.eujim.2015.02.002
   Web of Science ®Google Scholar
• Courneya KS, Segal RJ, Gelmon K, et al. Predictors of adherence to different types and doses of supervised exercise during breast cancer chemotherapy. Int J Behav Nutr Phys Act. 2014;11:85. doi:10.1186/s12966-014-0085-024997476
   PubMed Web of Science ®Google Scholar
• Aceto N, Bardia A, Miyamoto DT, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158:1110–1122. doi:10.1016/j.cell.2014.07.01325171411
   PubMed Web of Science ®Google Scholar
• Zhou F, Drabsch Y, Dekker TJ, et al. Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling. Nature Commun. 2014;5:3388. doi:10.1038/ncomms438824584437
   PubMed Web of Science ®Google Scholar
• Wright MD, Ni J, Rudy GB. The L6 membrane proteins – a new four-transmembrane superfamily. Protein Sci. 2000;9:1594–1600. doi:10.1110/ps.9.8.159410975581
   PubMed Web of Science ®Google Scholar
• Zukauskas A, Merley A, Li D, et al. TM4SF1: a tetraspanin-like protein necessary for nanopodia formation and endothelial cell migration. Angiogenesis. 2011;14:345–354. doi:10.1007/s10456-011-9218-021626280
   PubMed Web of Science ®Google Scholar
• O’Donnell RT, DeNardo SJ, Shi XB, et al. L6 monoclonal antibody binds prostate cancer. Prostate. 1998;37(2):91–97. doi:10.1002/(SICI)1097-0045(19981001)37:2<91::AID-PROS5>3.0.CO;2-O9759703
   PubMed Web of Science ®Google Scholar
• Marken JS, Schieven GL, Hellstrom I, Hellstrom KE, Aruffo A. Cloning and expression of the tumor-associated antigen L6. Proc Natl Acad Sci U S A. 1992;89(8):3503–3507. doi:10.1073/pnas.89.8.35031565644
   PubMed Web of Science ®Google Scholar
• Lee S, Kim TY, Kwak TK, et al. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis. J Cell Biochem. 2010;111:59–66. doi:10.1002/jcb.2287020506553
   PubMed Web of Science ®Google Scholar
• Shih SC, Zukauskas A, Li D, et al. The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis. Cancer Res. 2009;69:3272–3277. doi:10.1158/0008-5472.CAN-08-366019351819
   PubMed Web of Science ®Google Scholar
• Kuhn S, Koch M, Nübel T, et al. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res. 2007;5:553–567. doi:10.1158/1541-7786.MCR-06-038417579117
   PubMed Web of Science ®Google Scholar
• Giordano TJ, Shedden KA, Schwartz DR, et al. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol. 2001;159:1231–1238. doi:10.1016/S0002-9440(10)62509-611583950
   PubMed Web of Science ®Google Scholar
• Sun Y, Xu Y, Xu J, Lu D, Wang J. Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway. Int J Clin Exp Pathol. 2015;8(8):9081–9088.26464650
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. doi:10.1016/S0092-8674(04)00045-514744438
   PubMed Web of Science ®Google Scholar
• Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11:228–234. doi:10.1038/ncb182619255566
   PubMed Web of Science ®Google Scholar
• Vickers MM, Bar J, Gorn-Hondermann I, et al. Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis. 2012;29:123–132. doi:10.1007/s10585-011-9435-322120473
   PubMed Web of Science ®Google Scholar
• Wang X, Ling C, Bai Y, Zhao J. MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat Rec (Hoboken). 2011;294:88–92. doi:10.1002/ar.2128721157919
   PubMedGoogle Scholar
• Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H. miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res. 2008;68:5004–5008. doi:10.1158/0008-5472.CAN-08-018018593897
   PubMed Web of Science ®Google Scholar
• Chen X, Yan Q, Li S, et al. Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma. Cancer Lett. 2012;314:41–53. doi:10.1016/j.canlet.2011.09.01421983130
   PubMed Web of Science ®Google Scholar
• Park YR, Seo SY, Kim SL, et al. MicroRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targeting TM4SF1. Biosci Rep. 2018;38:BSR20180664. doi:10.1042/BSR2018066430135139
   PubMed Web of Science ®Google Scholar
• Fu Y, Zhao ZM, He QZ, Jiang BQ, Wu Y, Zhuang ZG. Hsa-miR-206 represses the proliferation and invasion of breast cancer cells by targeting Cx43. Eur Rev Med Pharmacol Sci. 2015;19(11):2091–2104.26125274
   PubMed Web of Science ®Google Scholar
• Song G, Zhang Y, Wang L. MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem. 2009;284:31921–31927. doi:10.1074/jbc.M109.04686219723635
   PubMed Web of Science ®Google Scholar
• Liu X, He M, Hou Y, et al. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma. Oncol Rep. 2013;29:1215–1220.23254912
   PubMed Web of Science ®Google Scholar
• Huang YK, Fan XG, Qiu F. TM4SF1 promotes proliferation, invasion, and metastasis in human liver cancer cells. Int J Mol Sci. 2016;17:661. doi:10.3390/ijms17050661
   PubMed Web of Science ®Google Scholar
• Cao J, Yang JC, Ramachandran V, et al. TM4SF1 regulates pancreatic cancer migration and invasion in vitro and in vivo. Cell Physiol Biochem. 2016;38:740–750. doi:10.1159/000445664
   Google Scholar
• Yang JC, Zhang Y, He SJ, et al. TM4SF1 promotes metastasis of pancreatic cancer via regulating the expression of DDR1. Sci Rep. 2017;7:4589.28676703
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–444. doi:10.1038/nature0720518650914
   PubMed Web of Science ®Google Scholar